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ABSTRACT
According to the Centers for Disease Control and Prevention (CDC), 8 million people
each year are infected with Mycobacterium tuberculosis (Mtb) leading to 1.5 million deaths
annually. This staggering number calls for advancements in understanding this bacterium so
progress can be made in treating and preventing the disease.

It is particularly important to

understand mechanisms by which TB survives inside hostile host immune cells known as
macrophages and within hypoxic granuloma lesions of the lung. Preliminary microarray data
has shown that a TB gene known as Rv2633c is induced upon macrophage invasion.
Bioinformatic analysis of Rv2633c coding sequence shows the product of Rv2633c has
homology with hemerythrin-like proteins. Hemerythrins are a class of proteins commonly used
to bind oxygen and sense nitric oxide and iron, leading us to hypothesize a role for Rv2633c in
surviving hypoxic or nitrosative stress encountered within macrophages and granulomas. My
first aim will be to generate a reporter strain of Mycobacterium smegmatis (Msm) expressing
the mCherry fluorescent protein driven by the Rv2633c promoter. This tool will allow us to
determine the stress conditions (i.e. hypoxia, nitric oxide treatment, acid pH) that activate
expression of this gene by measuring the change in fluorescence.

Linking the regulation of

Rv2633c to specific environmental cues relevant to infections in vivo will provide insight into
the role of this unique protein. Secondly, a knockout mutant of Rv2633c in the attenuated M.
bovis BCG will be constructed and characterized to determine the importance and function of
this protein during TB infections.
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CHAPTER 1: SPECIFIC AIMS
According to the Centers for Disease Control and Prevention (CDC), 9 million people
each year are infected with Mycobacterium tuberculosis (Mtb). Of those infected, Mtb kills 1.5
million annually (1). This staggering number calls for advancements in understanding this
bacterium so progress can be made in treating and preventing the disease. Understanding
mechanisms by which Mtb survives inside hostile host immune cells known as macrophages
and within hypoxic granuloma lesions of the lung are of particular interest. Preliminary
microarray data has shown that a gene of Mtb known as Rv2633c is induced upon macrophage
invasion. Bioinformatics analysis of Rv2633c coding sequence shows the product of Rv2633c
has homology to hemerythrin-like proteins. Hemerythrins are a class of proteins commonly
used to bind oxygen and sense nitric oxide, leading us to hypothesize a role for Rv2633c in
surviving hypoxic or nitrosative stress encountered within macrophages (2, 3). Recent analysis
of Rv2633c also revealed a previously unidentified Dps (DNA protection during starvation)
domain, which serves to protect DNA by protecting DNA under stressful conditions such as
hypoxia and starvation that Mtb encounters in vivo during infection (4-6). The major goal of this
project is to understand the role of Rv2633c during intracellular survival and persistent
infection of Mtb. We hypothesize that Rv2633c may use a hemerythrin-like protein to play a
key role in sensing oxidative stress from the environment and produce a Dps-like protein to
protect its DNA. By gaining additional knowledge into these crucial mechanisms, it will be
possible to better treat this disease for years to come.

AIM 1: To characterize the function and genetic organization of Rv2633c using bioinformatics
and transcript analysis.
We will use bioinformatics tools to analyze the Rv2633c genomic region in order to identify
potential functional domains, homologs, and promoter elements. In addition, RT-PCR will be
conducted to see if Rv2633c is co-transcribed with the adjacent gene Rv2632c. If the data
supports a linkage of the two, subsequent studies of Rv2633c would be designed to take the
possible involvement of Rv2632c into account.

AIM 2: To characterize the transcriptional regulation of Rv2633c using fluorescent reporter
bacteria strains
By fusing the fluorescent protein mCherry downstream of the promoter region of Rv2633c,
transcription levels can be easily measured under a variety of conditions. Additionally, the
fluorescent reporter strain will be transformed into wild type Mtb, a strain with a PhoP
mutation, and a strain with a WhiB3 mutation to confirm that these transcription factors
regulate Rv2633c. Fluorescence would be significantly lower in the mutant strain lacking the
transcription factor than the wild type if the gene is regulated by that protein. Stress inductions
will serve to identify environmental cues that activate this promoter. Based on the homology of
Rv2633c to hemerythrins and Dps, we will focus on the response of the bacteria to hypoxia,
nitric oxide, and stationary phase. Sequences crucial for promoter function will also be
identified by mutagenesis and measurement of fluorescence.
2

AIM 3: Use reverse genetics in Mycobacterium bovis BCG (BCG) to determine the phenotypic
effect of deleting Rv2633c.
A knockout of Rv2633c will be created in an attenuated surrogate for Mtb, BCG, using
homologous recombination by replacing the gene with a hygromycin marker. In parallel, senior
members of the lab will then transform the plasmid into wild type Mtb and observe the effects
under stresses discussed in Aim 2.
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CHAPTER 2: BACKGROUND
The Disease
Although any part of the body can be infected with TB, pulmonary TB is the most
common manifestation (23). Patients who have this disease develop a severe cough which can
even include coughing up blood, night sweats, and fever (23). Tuberculosis is transmitted
through the air by an infected individual coughing, spitting, speaking, or doing any other action
which could make the bacteria airborne (23). Often the disease will lay latent in the body for a
long period of time, frequently for a number of years, before the patient shows any symptoms.
This makes TB particularly dangerous, as one-third of those infected with the disease are
latently infected. Though an infected individual only has a 5-10% chance of developing TB once
they’re been exposed to it, the transmission process of TB is highly efficient. It can take only a
few Mtb cells to infect another individual (3).
The fact that tuberculosis is a deadly disease is no new development in the world.
Samples of spinal fluid in Egyptian mummies dated from 2400 BC have shown the presence of
tuberculosis in a number of victims (7). Hippocrates even noted in 460 BC that physicians
should not visit patients who had TB (although named “phthsis” at the time), because their
assured death would ruin the doctor’s reputation (7). It can be seen that TB has persisted for a
number of years, showing a slight decline around the discovery of penicillin, but increasing in
the number of cases in the 1980’s. Since then, the number of cases of TB has been on the
decline, although still highly prevalent (8).
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Tuberculosis will kill approximately 3 people every minute, and yet the most popular
treatment for the disease is outdated and requires close supervision. Treatment for both latent
and active TB requires the patient to take a cocktail of drugs for an extended period of time.
Following an initial dosage phase of two months, the patient must then continue to take many
antibiotics for an additional five to seven months (25). Frontline drugs for treating drug
susceptible TB include isoniazid, rifampin, ethambutol, and pyrazinamide. TB treatments must
be taken carefully, because taking the drugs incorrectly or not finishing the treatment can cause
the TB still alive to become drug resistant, which as a result is much harder and expensive to
treat (25). Unfortunately, many strains of Mtb have become drug resistant to many of these
common treatments. Drug resistant strains require second-line drugs that have a longer
duration period and more side effects than the frontline treatments (23, 25). Future research
on Mtb must focus on mechanisms that can be inhibited to better fight the disease.
Additionally, a vaccine for Mtb is available consisting of an attenuated strain of M. bovis
known as BCG. However, Mtb vaccines given to children are often not effective in adults (1, 9,
23). In many foreign countries receiving the vaccine is common, especially in areas where HIV
and other diseases which attack the immune system are prevalent. Those who work in
environments where tuberculosis is common may receive the vaccine as well. While BCG has
proven effective for preventing TB in infants, its efficacy in adolescents and young adults has
not been successful in preventing pulmonary TB (1). Many citizens born within the United
States have not received this vaccine due to its low efficacy rate and the low probability of
being infected with Mtb in the country. BCG also interferes with tuberculin tests, screens which
5

monitor if someone has developed tuberculosis. This causes false positives in patients, making
it difficult to determine where a tuberculosis infection may be in population (25). Due to the
overall lack of efficacy of the BCG vaccine to prevent the form of TB most responsible for
disease transmission, it is clear that this vaccine is not acceptable for the world-wide demand of
an effective TB vaccine.
The global TB crisis stems from the fact that modern drugs, vaccines, and diagnostic
techniques used to fight the disease are not adequate to effectively control the disease. For this
reason, WHO developed the six point “Stop MTB” strategy which includes building awareness
of the drug and getting vaccines to rural areas. Emphasis is currently placed on funding research
to generate new drugs and vaccines, and to improve upon treatments currently available (23).
These goals were set to be reached by 2015, and WHO has fallen drastically behind.

Evolutionary History
The Mycobacterium tuberculosis complex (MTC) is a group of closely related
mycobacteria (>99.5% identical) that cause TB of some sort (10). Figure 1 shows an
evolutionary tree of members of the MTC and their relation to other mycobacteria. From this
diagram it can be seen that species of mycobacterium most closely related to Mtb (which form
the MTC) display the most similar symptoms of the disease, while increasing evolutionary
distance from the MTC contains bacteria that are gradually less pathogenic. M. bovis commonly
infect cows, and M. tuberculosis infects humans. M. ulcerans and M. marinum can create
6

lesions on the skin of humans, but M. marinum is obtained from aquatic sources (11). One step
further shows species which are not as pathogenic; M. paratuberculosis can commonly be
found in the environment and are usually not harmful to humans unless they are severely
immunocompromised. Finally, fast-growing nonpathogenic mycobacteria like Msm are the
most evolutionarily distant species.
It was once thought that Mtb may have been transmitted to humans from cattle around
9,000 years ago, but it can be seen that this is not the case. More recent research suggests that
M. tuberculosis preceded M. bovis, and that humans may have actually infected cattle first with
the disease which then diverged into a species specific agent. The competing view holds that
both M. tuberculosis and M. bovis diverged at similar times from a founder strain (3, 12).

Figure 1: Evolutionary tree of common Mycobacterium species. The evolutionary tree depicts that species
such as M. tuberculosis and M. bovis that cause tuberculosis in humans and cattle respectively, are more closely
related than species like M. ulcerans which causes severe blister-like skin lesions or Msm which does not cause
disease.
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Conservation of a genetic region typically indicates an important part of the genome. By
comparing genomes across species, it is possible to predict which conserved regions are likely
vital to pathogenesis by relating it to the species that have gained or lost the sequence. For
example, a conserved sequence among virulent strains of a pathogen that has been modified or
lost in non-virulent relatives may indicate a mechanism by which the strains are virulent.
Likewise, a gene conserved only in human pathogens may indicate a mechanism by which the
pathogen survives in the human body. This type of assumption is based on one of Koch’s
molecular postulates, “the phenotype or property under investigation should be associated
with pathogenic members of a genus or pathogenic strains of a species”. Keeping this in mind, it
is important to investigate members of the Mycobacteria family in order to determine what
commonalities are present between branches of the family (13). This will help to determine
what sort of strategies Mtb adopts to so efficiently infect humans.
Since Mtb must be contained in a BSL 3 Laboratory, safer surrogate organisms are often
used to study mycobacterial genetics and virulence factors. BCG (Bacille Calmette-Guerin), the
attenuated M. bovis used in TB vaccines, is >99% identical to TB (10). This high level of similarity
to the pathogenic strains make it a good substitute for conducting experiments in a BSL2
environment. During the course of this investigation, Msm will also be used as a surrogate
organism since it is fast growing unlike BCG which can take weeks to form a colony.
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Mycobacterium tuberculosis Pathogenesis
One striking characteristic of TB pathogenesis is its ability to survive within its human
host for an extended amount of time (14). The pathogen has evolved particular mechanisms
which help it to survive within the conditions presented by the host cell, but little is known
about these adaptations. The ability to survive and replicate within macrophages remains one
of TB’s best strategies for surviving within a host for many years. Macrophages are large
phagocytic cells that are members of the immune system, and are recruited to sites of infection
to eradicate any foreign cells. TB has acquired the ability to not only survive within the nutrientlacking environment of these cells, but is also able to replicate inside of them (15). It is within
these cells that TB spends much of its infectious cycle within humans. The conditions within
macrophages are much different than the environment around it, encountering stresses
including antimicrobial peptides, low pH, hypoxia, reactive oxygen and reactive nitrogen
species, as well as lipases, proteases, and DNAases. TB must also have the ability to quickly
adapt between the many differing environments (3, 15).
In order to understand this relationship between macrophages and Mtb, it is important
to look at how the environment is formed. Initially, Mtb bacilli are inhaled into the lungs where
the bacterial cell is phagocytized by macrophages residing in the local alveolar tissue. Here, an
inflammatory response is induced, which brings foamy macrophages, mononuclear cells, and T
lymphocytes to the infection site. The outside of the conglomeration is then coated with
collagen and other fibrous material that forms a hardened surface to the structure. These cells
form a barrier around the infected macrophages, and the lesion as a whole is called a
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granuloma (or tubercle, where the disease gets its name), which is the body’s attempt at
localizing the infection (3).
Approximately 9% of TB cases are asymptomatic because the immune response has
successfully localized infection. However, when the integrity of the immune system fails the
granuloma will collapse in a process known as cavitation, disseminating many viable Mtb cells
into the host. Reasons for immune system changes could be the result of old age, HIV, or stress,
which are all common for many people infected with tuberculosis (23). The release of the
granuloma contents produces a severe cough that is one of the symptoms for tuberculosis.
Coughing also causes the spread of the disease through the air (3).
It is the center of this formed granuloma and macrophages that has been shown to be
hypoxic. Many bacteria would die under such conditions, but Mtb can persist and replicate in
such low levels of oxygen which indicates specific mechanisms for sensing the environment and
adapting as necessary must be present (15). Transcription factors are sets of genes that help a
pathogen establish its virulence inside a host. Two transcription factors which have been
proven to be required for Mtb in both macrophages and in vivo are PhoPR and WhiB3 (16, 17,
26). Since these transcriptional regulators are activated in response to hypoxia, acidic pH, and
oxidative stress, the genes they regulate must have some key feature in the ability for the
pathogen to survive. Understanding the roles of genes influenced by these transcription factors
will help to see what mechanisms Mtb uses to survive these conditions.
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Microarray
Microarray experiments performed by Dr. Kyle Rohde suggested a role for a gene called
Rv2633c during macrophage survival and implies that the gene may be regulated by both
PhoPR and WhiB3. When invading and growing within macrophages, mRNA levels of Rv2633c
were much higher than when the cell is not exposed to stress (14).
Relative mRNA levels during macrophage infection of Rv2633c in wild type Mtb in ratio
to a phoPR and whiB3 mutant are displayed in Figure 2. Expression of Rv2633c and its
adjacent gene Rv2632c are markedly lower in mutant strains of Mtb than in the wild type
strain, suggesting the genes may be regulated by these transcription factors.

Figure 2: Microarray Data for Rv2632c and Rv2633c mRNA Levels in PhoPR and WhiB3 Mutants. Levels
of Rv2632c and Rv2633c can be seen to fluctuate in similar patterns in the PhoPR and WhiB3 mutants. This may
indicate possible existence on the same operon.
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Levels of Rv2632c and Rv2633c exhibit similar expression profiles in mutant strains
(Figure 2), indicating they may possibly be located on the same operon. Both genes are not
activated two hours after macrophage infection, but expression is very high at days 2 and 4,
tapering off until day 12 (Figure 3). If the two gene being on an operon were the case, it would
be important to take into account the role of Rv2632c when determining the role of Rv2633c.
Being transcribed on the same operon may link the genes to similar functions, or functions that
would be sensed and activated by common environmental cues.

Figure 3: Microarray heat map expression data for Rv2632c and Rv2633c . The data showed that that
Rv2633c and its adjacent gene, Rv2632c, have similar expression profiles during macrophages infection.
The two mRNA transcripts are most abundant around day 2 and expression level drops significantly
around days 10 and 12.
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CHAPTER 3: MATERIALS AND METHODS

Bioinformatics Investigation
Analysis of Rv2633c was done in silico using existing databases that compared the
sequence and structure of Rv2633c to homologs in similar bacteria. Using sites such as
tbdb.org and xbase.org, the Rv2633c region was compared in both pathogenic and
nonpathogenic species of mycobacterium. A BLAST (basic local alignment sequence tool) search
was also utilized to look for sequence alignments and conclude any potential structures of the
resulting protein. Lastly, array data in these databases was used to identify and analyze
expression patterns of the genes of interest.

Cell Culture
Throughout this project, several different strains of bacteria will be used that all grow
and thrive optimally in different environments. The amount of time it takes to obtain a culture
of a certain bacteria will depend on what is being studied, as some species take longer to grow
than others. Below is an overview of what conditions were used for each species.
Escherichia coli (E. coli) cultures are typically grown on agarose lysogeny broth (LB)
plates with antibiotic added to the plate. This will depend on what plasmid is being studied as
selectable markers will vary. E. coli is typically grown in overnight cultures of 10 ml with 50 µL
of 50 mg/ml antibiotic added. Cultures are shaken overnight at 250 rpm at 37°C.
13

Msm was grown in LB broth with Tween added. Since the cell wall of Msm is waxy, cells
will clump together and the addition of Tween detergent prevents this from happening. Msm
uses antibiotics like E. coli does, but are grown for about two days at 37°C, shaken slowly at ~50
rpm.

Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR) provides a way to amplify a DNA fragment of interest
exponentially using DNA polymerase and primers to target the sequence of interest. Primers
are short strands of DNA which are designed to flank the DNA fragment which will be amplified.
The DNA template contains the desired amplified piece. Forward and reverse primers anneal to
a specific region of the template and polymerase binds to these regions, synthesizing new
strands complementary to the template using deoxynucleotide triphosphates (dNTPs). The
reaction is then repeatedly heated and cooled in a thermal cycler, causing the fragments to
multiply many times.
A typical PCR reaction contains 16.5 µl de-ionized water, 5 µl 10x GC buffer, 1 µl DNA
template, 1 µl forward primer, 1 µl reverse primer, 0.5 µl deoxynucleotide triphosphates
(dNTPs), and 0.25 µl Phusion polymerase for a reaction total of 25 µl. A standard PCR cycle is
shown below:
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98°C- 30 seconds
98°C- 10 seconds
x°C- 30 seconds

x17

72°C- y seconds
72°C- 5 minutes
25°C- hold
The variable x represents the appropriate annealing temperature for the two primers to
hybridize with their target sequence. Based on optimal Phusion parameters, primers are
typically designed to work at 65°C using a Tm calculator. This temperature can be calculated
using the Tm calculator available online from New England Biolabs by entering the primer
sequence into the calculator. The variable y represents the extension time for the reaction.
Typically, the time should increase by fifteen seconds for every kilobase of target sequence
length. For example, a 2,000 bp piece would have an extension time of 30 seconds.
Once the PCR is complete, the reaction is run on an agarose gel to confirm that there is
a band at the correct molecular weight by comparison to a ladder of known band size run
parallel to the sample. This verifies that the fragment of interest was properly amplified.
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FastCloning
Rationale: Recombinant DNA technology provides a way to create new pieces of DNA by
combining fragments of different function or origin for a variety of experimental applications.
The product is a new DNA construct which can then be expressed, or cloned, into a host cell
and the DNA will be present. Generating recombinant DNA products has traditionally been a
long and tedious process. Standard methods have relied on restriction enzyme digestion, which
requires a specific sequence of DNA to be present for the enzyme to cut. The DNA fragment of
interest is then inserted at the restriction site, but this means that the fragment is limited to
which restriction sites and enzymes are available. DNA fragments must also be purified on an
agarose gel to ensure fragments are the right size and that any contaminating pieces are not
present. Ligation is necessary to then seal any gaps in the final DNA construct, which adds yet
another step to the process.
A method widely utilized during this project is a polymerase chain reaction (PCR) based
cloning method called FastCloning, which is purification, digest, and ligation free (18). Because
FastCloning does not use the traditional methods of restriction enzymes but relies on primer
design, it is possible to insert a fragment into any position on a plasmid vector, provided the
sequence of the insertion site is known.
Method: Both the insert and the vector were amplified using PCR. Primers are designed
to amplify the vector into a linear piece of DNA, open at the desired position at which to insert
the fragment. Once the two reactions were verified on a gel, they were mixed together at a 1:4,
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1:1, and 4:1 insert to vector ratio at a total volume of 8 μl. The mixtures then had 2 μl of DpnI
added which digested the methylated strands of DNA. DpnI will digest original, methylated
plasmid DNA but not the unmethylated insert and vector fragments generated by PCR. This
serves to eliminate false-positive clones that would result if the template plasmid is introduced
into E. coli during transformation. This allows users to forego the time consuming vector
digestion and purification steps traditionally performed in other cloning methods. Once the
insert, vector, and DpnI reactions have been incubated at 37°C for one hour, they are directly
transformed into chemically competent NEB 10-beta E. coli cells.
Transformation of the FastCloning reactions began by thawing the NEB 10-beta E. coli
cells on ice for 10 minutes. 1-5 µl of the FastCloning mix was then added to an aliquot of the
thawed cells and placed on ice for 30 minutes, followed by a 42°C heat shock for 30 seconds
and placed on ice for 5 minutes. Following addition of 200 µL of SOC, the mix was then shaken
at 250 rpm at 37°C for one hour. After incubation, 50-100 µl of the reaction is plated on LBhygromycin plates.
The plates which are used during the transformation contain antibiotic that selects for
the amplified plasmid. In the case of this study, the pVV16 vector has a hygromycin marker, so
the transformations were plated on Hyg50 (50 μg/ml) LB plates. Any colonies that appear as a
result of the transformation should contain plasmids possessing the desired insert because only
then will they possess the antibiotic resistance gene. However, false positives can arise from
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incomplete Dpn1 digestion or rare self-ligation of the fragment alone. For this reason, these
colonies are then screened using the colony PCR method detailed below.
To screen for positive clones, a small colony from any plate is selected at random and
boiled in 20 μl of water for 5 minutes in order to release their DNA. The sample is then
centrifuged at 10,000 xg for 5 minutes so that cellular debris will collect at the bottom of the
tube. The lysate containing DNA from the colony is then used as the template DNA in a PCR
reaction. For colony screening, primers used to amplify the insert will be used. Since the
selectable marker ensures that only colonies which have taken up the plasmid can grow on the
plate, this step confirms that the insert is present too. The cycle used will be the same as in
standard PCR, but with 30 cycles instead of 17.
Once positive colonies have been confirmed, it is inoculated into LB broth plus antibiotic
to culture the clones containing the desired plasmid. The plasmid is then purified and the
plasmid extracted from the sample using an alkaline lysis protocol from Qiagen, and positively
cloned DNA is then obtained. The DNA is then sequenced to verify that mutations are not
present.

Creating the Promoter Reporter Strain
Rationale: By engineering fluorescent protein expression to be driven by a specific
promoter, we will generate a powerful tool to facilitate the study of gene regulation. Reporter
strains allow real-time measurement of promoter activity in the whole cell using a plate reader.
18

As the promoter of interest is activated, the fluorescent protein downstream of the promoter is
transcribed and fluorescence levels of the culture will increase. This reporter strain will also
contain a dual color approach, using green fluorescent protein (GFP) and mCherry to detect
ratiometric changes.
Method: A shuttle vector called pVVRG will be used that has the ability to replicate in
both E. coli and mycobacteria. This vector contains green fluorescent protein (GFP) controlled
by a strong hsp60 promoter and mCherry downstream of a second strong promoter called
smyc. This shuttle vector also features kanamycin and hygromycin resistance.
Primers were designed to amplify a ~500 bp region upstream of Rv2633c containing the
promoter from Mtb chromosomal DNA (1 µl chromosomal TB DNA at 20 ng/µl, 1 µl primer 1:
2633pro_mCh_F, 1 µl primer 2: 2633pro_mCh_R, 0.25 µl dNTP, 5 µl GC Buffer, 0.25 µl Phusion
High Fidelity DNA Polymerase, 16.50 µl De-ionized water, for a 50 µl total; primers work at a
67°C annealing temperature with a 30 second extension time). The pVVRG plasmid was also
amplified (1 µl chromosomal TB DNA, 1 µl primer 1: pVVmCh_FC_F, 1 µl primer 2:
pVVmCH_FC_Rpro, 0.25 µl dNTP, 5 µl GC Buffer, 0.25 µl Phusion High Fidelity DNA Polymerase,
16.50 µl De-ionized water; primers work at a 65°C annealing temperature with a 1.5 minute
extension time).
FastCloning will allow the smyc promoter of pVVRG to be replaced by the Rv2633c
promoter via homologous recombination. The product of this transformation is then PCR
screened for positive clones, and confirmed by sequencing for accuracy [5].
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Once this sequence has proven to contain no mutation, it was electroporated into Msm.
This was required because the cellular membrane of Msm is particularly thick. As Figure 4
shows, the result of this transformation was a pVVRG derivative with the Rv2633c promoter
driving the mCherry promoter. By measuring changes in the ratio of mCherry fluorescence to
baseline GFP fluorescence (a control), the activity of the Rv2633c promoter could be
monitored.

Figure 4: Creating the Fluorescent Promoter Reporter Strain. The promoter reporter strain was created
by first amplifying the Rv2633c promoter region in front of the Rv2633c gene (A). A preexisting plasmid
known as pVVRG contained a strong smyc promoter in front of a sequence coding for the fluorescent
protein mCherry. This plasmid also features a GFP sequence paired with another promoter for the
purpose of a control (B). FastCloning of the Rv2633c promoter region and pVVRG replaced the smyc
promoter with the promoter of Rv2633c, and the activity of the promoter can then be monitored by
mCherry levels (C).

The fluorescence level of GFP will be consistent throughout any condition the bacteria is
exposed to because the strong, hsp60 promoter will not be affected by the cell’s environment.
Since the Rv2633c promoter will respond to the environmental stresses and activate mCherry

20

expression, the ratio of mCherry to GFP fluorescence will indicate the relative induction of the
Rv2633c promoter.
In addition to plate reading, the colonies containing the pVVRG2633c construct were
observed underneath a fluorescent microscope (EVOS FL). A positive colony from the Msm
plates was lightly streaked onto a glass slide and fixed into place with a cover slip. Images were
captures using both Texas Red and GFP filters to visualize mCherry and GFP signals produced by
pVVRG2633c Msm.
In the future, we plan to see if Rv2633c is induced by hypoxia stress by incubating the
reporter strain under normal oxygen levels and hypoxia (~1-5 % O2) in a hypoxia chamber. The
ratio between GFP and mCherry will indicate if Rv2633c is responsive to hypoxia; an increase in
mCherry fluorescence indicates induction. Additionally, links to PhoP indicate a relation to
acidic conditions. A gradient of pH with liquid media buffered to a variety of pH levels (~pH 57) will be used to determine if the Rv2633c is upregulated when these conditions are present.
Once the construct was confirmed to work in Msm, the construct was transformed into
Mtb and BCG for further experimental purposes. Since Msm does not have an Rv2633c
homologue, using the construct in Mtb and BCG may more faithfully mimic the “real life”
situation. Since Mtb must be handled in a BSL3 laboratory, this part of the project was carried
out by a different member of the team who has access to the laboratory. However, BCG could
be used for additional experiments in a BLS2 setting, and then confirmed in Mtb. All strains will
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be exposed to various environmental conditions and monitored using the fluorescent strain as a
reporter of activity.

Characterizing the Promoter
Rationale: In addition, our reporter system can be used for detailed characterization of
the Rv2633c promoter itself. PCR-based mutagenesis will be utilized to truncate the ~500 bp
region which is assumed to contain the true promoter. Fragments of this region will be deleted
while mCherry will be measured until the fluorescence drops, indicating the loss of genetic
elements essential for either Rv2633c basal expression or stress induction by PhoP and WhiB3.
This will allow us to characterize the sequence required for basal activity of the gene, and the
Rv2633c promoter will be defined.
The initial promoter region cloned upstream of mCherry included ~500 bp that was
chosen because most promoters are found within this range.

The true promoter was

somewhere in this region, but not fully defined. An approach called Round-the-horn PCR (RTHPCR) (19), which can delete small fragments of DNA or perform point mutations, was utilized to
modify the Rv2633c promoter region in the Rv2633c:mCherry reporter construct in order to
find the true promoter region. Additional shorter fragments of this region were also prepared
to be tested.
This approach involves designing a forward primer which hybridizes at a position
defining the downstream fragment, and a reverse primer that encodes for the upstream part of
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the region that will be kept. This puts the deleted fragment of the gene between the two
regions which the primers amplify. These primers are phosphorylated prior to amplification.
Thus, when these primers amplify the fluorescent reporter plasmid, only the part of the vector
which contains the desired sequence is made and the fragment which is being deleted is not
present. The PCR product is then ligated together using the phosphorylated ends of the primer,
as Figure 5 shows. This new, truncated plasmid is then transformed into E. coli and expression
of mCherry is monitored with a plate reader.
Method: The forward and reverse primers were first individually phosphorylated at 37°C
for one hour (37.5 μl de-ionized water, 5 μl 10x kinase buffer, 1 μl 100 mM ATP, 0.5 μl 100 mM
MgSO4, 5 μl 10 μM primer, 1 μl T4 Polynucleotide Kinase (PNK)). They were then incubated at
65°C for 20 minutes to heat inactivate the T4 PNK.
Next, the phosphorylated primers were utilized in a PCR to amplify the desired section
of a plasmid while omitting the area between the primers (Forward primer: 2633pro_mCh_F2,
Reverse primer: pVVmCh_FC-Rpro). Once the PCR reaction is complete, the product was run on
an agarose gel to ensure that a fragment of the correct size was obtained. This fragment will be
the size of the original plasmid minus the amount deleted.
When the fragment appeared to be the correct size, 2 μl of DpnI was then added to the
mix and incubated at 37°C for 2 hours. Once the incubation was complete, the PCR product was
ligated together using the phosphorylated ends of the primers to re-circularize the plasmid (1.5
μl Fast-link ligation buffer, 0.75 μl 10 mM ATP, 3 μl PCR product, 1 μl Fast-link DNA ligase, 8.75
23

μl de-ionized water; incubated at room temperature for 2 hours, then heat inactivated the Fastlink DNA ligase at 70°C for 15 minutes). This time when the ends are joined together, the
plasmid did not contain the deleted section. After the final incubation is complete, the reaction
mix was transformed into competent E. coli cells.

Figure 5: Characterizing the Promoter. (A) Characterizing the promoter utilizes a method known as
Round the Horn PCR. First, phosphorylated primers are used to amplify the pVV16 plasmid containing
the promoter region of Rv2633c, but a small area which will be deleted is omitted from amplification.
(B) Once the PCR is complete, the promoter region does not contain a certain region of the original
sequence and the ends of the fragment are also phosphorylated. (C) The phosphorylated ends of the
fragment are ligated together, re-circularizing the plasmid which now has a truncated promoter region.

Using a plate reader, fluorescence will indicate which constructs contained the
promoter region. Fluorescence which matches that of the ~500 bp region will be from colonies
that have retained activity. Partial loss of fluorescence would indicate that a promoter is still
present, but has some transcription factor binding sites missing. A loss of fluorescence will
mean the baseline promoter region has been truncated and lost. At this point it will be known
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that the true promoter has been disturbed and point mutations will be made to define specific
base pairs required for wild-type promoter activity.

Generating an Rv2633c Knockout Mutant
Rationale: Reverse genetics provides a way to observe the phenotype of an organism
when a particular gene is missing. Using homologous recombination, the gene of interest will
be replaced with a hygromycin marker while the areas adjacent to the gene will be left intact.
By applying this approach, it is possible to understand the importance of a gene of interest by
observing what happens to an organism when it is not present.
Method: This process includes cloning regions of the DNA that flank the gene targeted
for deletion on either side of a hygromycin selectable marker in the pFCKO knockout vector
created in the Rohde lab. FastCloning as described in detail above will be used in order to
create this knockout plasmid.
The vector used for this method, pFCKO, contains many unique features. The first of
these is a Hyg marker flanked on either side by loxP sites, which allow removal of the marker by
Cre recombinases. This is favorable because selectable markers in Mtb are limited and removal
of the Hyg marker will allow reuse of this marker. As mentioned above, ~1 kb regions on either
side of the gene of interest are inserted upstream and downstream of the Hyg marker using
standard FastCloning, as Figure 6 shows. Once this construct has been prepared, it is ready for
transformation.
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A double crossover event will result in the knockout construct replacing the wild type
gene. However, single crossover events which integrate the whole plasmid into the
chromosome are an unwanted possibility. The rpsL gene is a counterselectable marker on the
pFCKO vector that allows us to filter out the single cross over event. Bacteria which undergo
single crossover and take up the rpsL gene are sensitive to streptomycin and they will not grow
on a plate containing strep.
To amplify a ~1 kb fragment directly upstream of Rv2633c, forward primer 2633c_Up_F
and reverse primer 2633c_Up_R were used in a PCR including Mtb chromosomal DNA as the
template. Next, the pFCKO vector was amplified using primers that linearized the plasmid at a
point directly upstream of the Hyg marker (forward primer: pFCKO_Up_F and reverse primer:
pFCKO_Up_R). Standard FastCloning was used to insert the upstream fragment into the plasmid
at the correct point. Once colonies were obtained on a plate, screening occurred using the
same primers used to amplify the upstream fragment to ensure that the insert was successfully
in the plasmid. This clone was name pFCKO_2633Up, meaning that the pFCKO vector had the
2633c upstream region cloned into it.
A similar process occurred for the downstream fragment. A downstream region of ~1 kb
directly adjacent of Rv2633c was amplified using forward primer 2633_Dn_F and reverse
primer 2633_Dn_R. The pFCKO_2633Up plasmid was amplified using primers that opened the
DNA at the region directly downstream of the hyg marker (forward primer: pFCKO_Dn_F and
reverse primer pFCKO_Dn_R). Once again, FastCloning was utilized to combine the Rv2633c
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downstream fragment and the opened pFCKO_2633Up DNA. Once colonies were grown, the
downstream fragment primers listed above were used to screen the colonies to ensure that the
downstream fragment was present. If these screens indicated the fragment was present, the
construct was taken into consideration to be the final knock out, but named pFCKO_2633c until
a final screening method could verify the knockout plasmid construction was a success.
An additional screening step was used to ensure all three essential element of the
pFCKO vector are present in the construct. Two primers called M13R and M13F that flank the
knockout construct were used to amplify across pFCKO_2633c. Since the upstream fragment,
Hyg marker, and downstream fragments were all ~1kb individually, colonies containing the
desired construct were expected to produce bands at ~3,000 bp. If bands were seen at ~2,000
bp or ~1,000 bp, it would indicate that one or more of these elements were missing.
This plasmid can then be electroporated into mycobacteria where it will cross into the
chromosome by homologous recombination, effectively deleting Rv2633c from the
chromosome. Positive knock-out clones can be identified by their ability to grow on agar plates
containing hygromycin (50 g/ml) and streptomycin (100 g/ml). The knock out will then be
assessed by its growth and survival under in vivo stresses such as hypoxia, nitric oxide, acidic
pH, and in macrophages.
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Figure 6: Creation of the Rv2633c Knock-Out Strain. (A) Creating the knock out was done in a two-step
process. First, the regions 1,000 bp upstream and 1,000 bp downstream of Rv2633c were amplified (B)
and cloned on either side of a Hyg marker using two separate FastCloning steps. (C) This construct was
the transformed into Mtb, (D) where a double cross over event caused the construct to be incorporated
into the genome.
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Reverse Trascriptase PCR (RT-PCR)
Rationale: Bacterial genes are often arranged in operons, which include multiple genes
transcribed from a single promoter on a single mRNA transcript. Frequently, genes located on
the same operon are co-regulated meaning they may have similar function. RT-PCR will be
conducted to see if Rv2633c is co-transcribed with the adjacent gene Rv2632c. If the data
supports a linkage of the two, subsequent studies of Rv2633c would be designed to take the
possible involvement of Rv2632c into account.
To determine whether two genes are transcribed into a single mRNA, Mtb mRNA can be
transcribed back into DNA using an enzyme known as reverse transcriptase (RT). The cDNA will
contain genes in their respective operons since this DNA will be obtained from mRNA present in
the bacteria. In order to determine if Rv2632c and Rv2633c are located on the same operon,
primers on either side of the gap between the genes will be used to determine if the two genes
are transcribed together. If Rv2632c and Rv2633c are on the same transcript, then primers
designed to amplify the intergenic region between them will generate a product. If they are not
on the same transcript, the primers will be targeting two separate cDNA pieces and the
fragment will fail to amplify. As a result, there would be no bands on the agarose gel.
Method: During RT-PCR, Mtb RNA was reverse transcribed into complimentary DNA
(cDNA) by reverse transcriptase enzyme (4 μl iScript reaction mix, 1 μL iScript reverse
transcriptase, 1 µl RNA (100-250 ng/µl), 14 μL Nuclease-free water; Reaction times may be
carried out in a thermocycler: 25°C- 5 minutes, 42°C- 30 minutes, 85°C- 5 minutes, store at 4°C).
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Once the cDNA is obtained, it was used as a template for a standard PCR with primers that flank
the gap between the two genes (Forward primer: Rv2632/33_F, Reverse primer: Rv2632/33_R).
The PCR was then imaged on a 1% agarose gel.
Two controls will be used for this experiment. In one, RNA would be added to the PCR
reaction without adding any reverse transcriptase (4 μl buffer, 1 µl RNA (100-250 ng/µl), 15 μl
nuclease-free water; the same thermocycler setting as the reverse transcriptase samples should
be used). This “No RT” control is to ensure that the RNA is not contaminated with any DNA
products. Since reverse transcriptase is not added to the RNA, no DNA should be present, and
no amplified bands would be expected. The positive control involves using the primers for the
RT-PCR (Forward primer: Rv2632/33_F, Reverse primer: Rv2632/33_R) on Mtb chromosomal
DNA. By adding this PCR reaction, it can be confirmed that PCR conditions were appropriate for
amplifying target RNA.

Quantitative Reverse Transcriptase PCR (qRT-PCR)
Rationale: As a method to quantify the mRNA levels of Rv2632c and Rv2633c in order to
determine their co-regulation, qRT-PCR will be utilized. Similar to the RT-PCR, qRT-PCR depends
on the reverse transcriptase enzyme in order to create cDNA out of Mtb RNA (using the same
procedure as RT-PCR to obtain cDNA). The qRT-PCR machine will use this cDNA as a template
for a PCR reaction which can quantitatively monitor DNA synthesis in real-time using SYBR
green, a fluorescent dye which intercalates into amplified products. Thus, detection of an

30

increase in fluorescence can be used to quantitate relative amount of mRNA transcripts. By
doing this, it is possible to determine if the levels of Rv2633c and Rv2632c are expressed at
similar levels and up-regulated under similar conditions, as would be expected if they were in
an operon. Samples from macrophage invasion will be used for this quantification in order to
see at what time period during infection Rv2633c and Rv2632c are transcribed. The PhoP and
WhiB3 mutants will also have their RNA extracted and quantified to determine how these
genes are regulated when their hypothesized transcription factors are mutated.
Method: Once cDNA is obtained, it is added to a Supermix which contains buffer, dNTPs,
polymerase, and SYBR green (12.5 μl iScript Universal SYBR Green Supermix, 2.5 μl Forward
primer, 2.5 μl Reverse primer, 5.5 μl de-ionized water). For this experiment, all reactions were
done in triplicate to ensure accuracy. Reaction 1 amplified Rv2632c and contained forward
primer Rv2632_F and reverse primer Rv2632_R). Reaction 2 amplified Rv2633c and contained
forward primer Rv2633c_F and reverse primer Rv2633c_R.
The last reaction was a control which amplified the sigA gene, which is vital for life in the
bacteria (Forward primer: SigA_F, Reverse primer: SigA_R). This gene is transcribed in steady,
constitutive levels in the cell, and is therefore used as a way to normalize the transcript levels of
other genes by measuring their rate of amplification in comparison to this mRNA transcript.
These reactions are all set up in a 96 well clear plate and read in a 7900AT Fast RT-PCR
Machine (Applied Biosystems). The PCR cycles are set to:
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95°C- 2 minutes
98°C- 10 seconds
X40
85°C- 30 seconds
Since sigA is needed in high quantities in the cell, it can be expected that its levels of
mRNA transcripts will be seen at about 21 cycles. To ensure the PCR worked, sigA is used as a
control to make sure this signal is seen around its typical amplification cycle. This signal can
then be used to normalize the rest of the data collected by calculating it with the ∆∆Ct method
(20). This method determines relative changes in mRNA levels by comparing samples to a
known control, normalizing the samples, and then comparing the samples to one another.
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CHAPTER 4: RESULTS
Bioinformatic Investigation
Using a basic sequence alignment, it was observed that the sequence coding for
Rv2633c is present only in species of mycobacterium which cause harm to humans (Figure 7). In
species which infect other animals (such as Mycobacterium marinum, which harms fish) and
slow growing species which are non-pathogenic the gene is not present, due either to loss by
non-pathogens or gain by pathogens. This data can support the hypothesis that this gene of
interest is utilized during pathogenicity in humans.

Figure 7: BLAST Alignment of Rv2633c and Surrounding Regions with Common Species of
Mycobacterium. The results of a BLAST search show that species that cause tuberculosis in humans and
other animals have retained the Rv2633c gene, where other species of mycobacterium which cause
some other type of disease or no disease at all have lost this gene.
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The sequence of Rv2633c also revealed the product of the gene to be a hemerythrin.
This is a class of protein which can bind oxygen and iron, and the hemerythrin binding domain
can be seen in Figure 8. BLAST analysis of the Rv2633c gene also revealed that the C-terminal
domain has homology to a protein (~1.8 kDa) known as Dps (DNA-binding protein from starved
cells). Dps also shows similarity to ferritins, indicating that the protein may also play a role in
ferritin storage.

Figure 8: Hemerythrin Binding Domain. (A) The hemerythrin binding domain common to all
hemerythrins consists of a bundle of four alpha helices. The domain typically binds iron or oxygen. (B)
The hemetrythrin binding domain is close to a Dps domain.
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Creating the Promoter Strain
A fluorescent reporter strain of the Rv2633c promoter was constructed in order to
observe the activity of the promoter region. By doing this, it will be possible to expose the cell
to a variety of stresses and use the fluorescent reporter to determine what conditions cause
the gene to be activated. In Figure 9, both wild type Msm and Msm with pVV2633RG were
plated on the same LB plate. It can be seen when the two cultures grow up side-by-side that the
cells with the Rv2633c promoter are visibly more pink than when the species does not have the
promoter driving mCherry.

Figure 9: Visual evidence for Rv2633c promoter activity in Msm. Msm pVV2633cRG shows visibly pink
colonies (right) versus wild type Msm (left).
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When a sample from the Msm pVV2633RG reporter strain was viewed under
fluorescent microscopy, both mCherry and GFP could be seen. Since both fluorescent reporters
were easily detected under a fluorescent microscope, the pVV2633RG construct was a success
and a dual-colored fluorescent reporter strain was successfully created (Figure 10). This
provides proof of principle for the use of this ratiometric reporter strain coupled with
fluorescent microscopy to monitor Mtb promoter activation during macrophage infection.

Figure 10: Fluorescent microscopy of pVV2633RG strain. Fluorescence microscopy imaging of Msm
pV2633RG on an EVOS FL shows both red and green fluorescence, indicating that the construct was a
success.
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To support fluorescent microscopy, a quantitative measure of fluorescence was
obtained using a plate reader. The amount of mCherry and GFP fluorescence was measured for
pVV2633RG cultures and pVVRG cultures (in which mCherry expression is driven by smyc
promoter). The bar graph displayed in Figure 11 shows the difference between the two strains.
It can be seen that pVV2633cRG Msm with the Rv2633c promoter has a much higher level of
mCherry than pVVRG Msm, indicating highly active promoter activity.

Figure 11: Plate reader data comparing mCherry and GFP fluorescence of pVV2633cRG and pVVRG.
Plate reader data shows the quantitative difference between the pVVRG fluorescent promoter
construct containing the Rv2633c promoter with the same plasmid lacking this promoter in Msm. The
Rv2633c promoter appears to be stronger than the smyc promoter.
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The pVV2633RG fluorescent reporter was then transformed into wild type Mtb, which
showed bright magenta colonies (Figure 12). This was beneficial because it proved that Rv2633c
has high levels of activity in Mtb.

Figure 12: Wild type Mtb contianing the Rv2633cRG fluorescent promoter construct. Wild type Mtb
transformed with pVV2633RG reveals high activity level of Rv2633c promoter.

Figure 13 shows the result of transforming both wild type Mtb and a ∆PhoPR mutant
with the reporter strain. Wild type Mtb once again shows bright pink colonies while the PhoPR
mutant is a dull, white color. This result confirms that Rv2633c may be regulated by this
transcription factor, and in the absence of PhoPR Rv2633c is not actively transcribed.
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Figure 13: Fluorescent Rv2633cRG promoter strain transformed into wild type Mtb and a PhoP
mutant. Expression of Rv2633c is visibly reduced in the ∆phoPR mutant compared to wild-type Mtb.

Cultures from both the wild type Mtb and ∆PhoPR mutant Mtb were read in a plate
reader. The data displayed in Figure 14 shows a significant drop in mCherry levels between the
two cultures, with the wild type Mtb reporting a much higher level of Rv2633c than the PhoPR
mutant. This leads us to conclude that the PhoPR two-component regulator controls Rv2633c.
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Figure 14: Fluorescence levels of the Rv2633cRG construct in wild type Mtb and a PhoP mutant. Plate
reader data of strains from Figure 13 show that mCherry levels drop about 4.5x in ∆phoPR.

Characterizing the Rv2633c Promoter
An approach called ‘Round-the-horn, was used to find the baseline sequence needed for
promoter activity. In this approach we will delete some of the preexisting ~1 kb region
upstream of the Rv2633c promoter and use a plate reader to monitor baseline activity.
Currently, primers amplifying the ~500 bp region have been ordered. They were proven to work
and optimized using standard PCR. The next step will be to phosphorylate the primers. Once
this mutant is transformed into E. coli, it will be possible to tell if the baseline promoter region
is located in the ~500 bp sequence by comparing the mCherry fluorescence to that of the ~1kb
upstream construct.
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Creating the Knock Out Strain
Reverse genetics provides a way to observe the phenol type of a cell when a gene of
interest is missing. In order to perform this type of experiment of Rv2633c, a knock out of the
gene was constructed. The gel in Figure 15 shows the screening process for obtaining this
mutant. In Lane 1, a band at 1,000 bp can be seen indicating only the Hyg marker was present
in the plasmid. Lane 2 shows the screening of the intermediate pFCKO_2633cUp construct.
Since at this step only the upstream fragment had been inserted into the vector, the band at
~2,000 bp is expected because the primers are amplifying both the upstream fragment and the
Hyg marker. In the last lane, the downstream fragment of Rv2633c was amplified and inserted
into the pFCKO vector already carrying the upstream fragment. During the final step of the
process, pFCKO_2633cKO was amplified and a band can be seen at ~3,000 bp. A band of this
size is correct since the upstream, Hyg marker, and downstream fragment are all present. The
knockout was considered a success, and this DNA can then be electroporated into
mycobacteria.
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Figure 15: Screening for positive clones during each step of generating the Rv2633c knockout. It can be
assumed that a knockout of Rv2633c was generated since the adjacent upstream and downstream
genetic portions appear to be successfully inserted at each step.

Reverse Trascriptase PCR
Since Rv2632c and Rv2633c exhibit similar microarray profiles under macrophage
invasion (See Figure 16), it is important to determine if the two genes are located on the same
operon. If they are, it is important to study both of the genes since they may have asimilar
function. Forward and Reverse primers are designed to amplify the intergenic region between
Rv2632c and Rv2633c. This product can only be obtained from cDNA if the two genes are cotranscribed on a single mRNA (operon) (Lane 1). For the “no RT” control, reverse transcriptase
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enzyme was omitted; a band in this sample would indicate DNA contamination in RNA sample
(Lane 2). The primers used to amplify the region were used to amplify the fragment on
chromosomal Mtb DNA as a control that the PCR worked (Lane 3). This data implies that there
was no contamination in the sample since no RNA was present in Lane 2. It can also be seen
that PCR was successful since the control in Lane 3 produced a band.

Figure 16: Reverse transcriptase PCR on wild type Mtb cDNA. Primers amplifying the intergenic region
between Rv2632c and Rv2633c did not produce a band, while the control showed that the PCR was
working properly.
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Quantitative Reverse Transcriptase PCR (RT-PCR)
During qRT-PCR, cDNA of wild type Mtb was amplified using primers specific for
Rv2632c, Rv2633c, and sigA. This provided a way to precisely measure the quantity of each
transcript present in the sample using SYBR Green fluorescent dye. The qRT-PCR data depicted
in Figure 17 shows the results of amplification done with a sigA control using wild type Mtb
RNA. The sigA control amplifies at the expected ~21 cycles, indicating the integrity of the
template RNA and success of the reactions. Amplification of Rv2632c and Rv2633c transcripts at
similar cycles indicated that both of our target genes are expressed at relatively high levels
under normal growth conditions. This assay can be used to monitor expression patterns of two
genes under different stress conditions to determine if they are coordinately regulated.
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Figure 17: qRT-PCR performed on wild type Mtb cDNA amplifying Rv2632c and Rv2633c. The graph
resulting from qRT-PCR amplifying the genes of interest show that Rv2632c and Rv2633c are amplified in
high quantities.
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CHAPTER 5: DISCUSSION
Mycobacterium tuberculosis is an extremely dangerous disease that infects millions
every year. This disease was acknowledged by WHO in the early 1990’s as a global health crisis
and since then researchers have begun focusing on understanding the disease better and
developing new drugs that will effectively combat the disease (23). Since the development of a
TB vaccine is difficult to optimize because of its complex interactions with the immune system,
efforts must be made to understand mechanisms by which the disease infects so that drugs
treating the disease can be more effective.
With this in mind, our research focuses on understanding a possible method by which
Mtb can survive in the stressful conditions on macrophages and granulomas of the human
body. This environment often has stresses such as hypoxia, hydrogen peroxide, and oxidative
stress that kills many infectious cells, but Mtb can survive and even replicate in such stresses for
many years (15). Here, we present a gene named Rv2633c that encodes a hemerythrin-like
protein which may be a helpful mechanism Mtb can use during stressful conditions.
Initial bioinformatics analysis of Rv2633c revealed an internal domain with significant
homology to a class of proteins known as hemerythrins. Hemerythins are a class of proteins
that have the ability to bind and store oxygen; many marine organisms possess high quantities
of hemerythrins, which can help to bind oxygen and help the organism survive in environments
where oxygen levels are low (2). Like marine environments, the oxygen levels are low inside of
a granuloma. Additionally, hemerythrins have been linked to iron binding, with domains that
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bind iron and increased levels of activity in iron-deficient environments (21). The presence of a
gene like Rv2633c could indicate a possible mechanism for adapting to such a condition, such as
sensing oxygen levels or storing oxygen in hypoxic environments. A previous study found that
an E3 ligase linked to an iron-responsive hemerythrin domain played a regulatory role in the
stability of the protein. The hemerythin acted as a switch that mediated the stability of the
protein (22). It is possible that the role is similar for a Dps-like protein in Rv2633c.
Rv2633c also includes a C-terminal domain with homology to a protein known as Dps
(for DNA protection during Starvation). A previous study found this protein to be present in
high levels during the stationary phase of bacterial growth (4). Additionally, Dps is a nonspecific,
DNA binding protein that can make a cell more viable in conditions such as increased hydrogen
peroxide levels and other oxidative stresses than cells with a Dps mutation (5-6). Interestingly,
Dps is actually more stable after binding to DNA. Unbound Dps could withstand temperature of
about 65°C before denaturing, whereas Dps bound to DNA withstood temperatures up to 100°C
(4). Our data reports a Dps homolog in Mtb, but prior to this study, it was thought that Mtb did
not have a Dps homolog (24).
If Rv2633c transcribes a hemerythrin and Dps, it is possible that the hemerythrin region
is used to sense the environment and Dps binds DNA for protection in response to an
environment with low oxygen or high oxidative stress. This means that this particular gene
could be a mechanism by which Mtb protects itself under the harsh conditions of granulomas
and macrophages. Like in the E3-ligase example, perhaps the hemerythrin domain regulates the
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stability of the Dps domain, and thus a DNA protection mechanism, in response to
environmental cues.
To our knowledge, this is the first study to characterize the role and importance of this
unique protein for Mtb pathogenesis. We used a variety of experimental approaches, including
fluorescent reporters, RT-PCR, and reverse genetics to investigate the regulation and function
of Rv2633c.
Our first goal was to design a genetic construct to monitor the regulation of the Rv2633c
promoter using a fluorescent protein called mCherry. Our data showed that the ~500bp
upstream region we cloned did contain elements required for promoter activity in Msm and
Mtb. The construct was remarkably bright in Mtb.

This construct can now be used to

determine when Rv2633c is activated in the cell. After transforming this reporter into a cell, the
bacteria can be exposed to various environmental stresses such as hypoxia, nitrosative stress,
and varying pH levels to determine how the gene is activated. After exposing the bacteria to
such conditions, the fluorescence of the cells will be measured using a plate reader. Those with
a higher fluorescence level indicate that the gene was activated, and those with no change
mean the gene was not activated. Using this data, it will be possible to see which conditions
cause the promoter to be activated by which stresses caused fluorescence to increase. The role
of Rv2633c can be implied from this data based on what it responds to in the cell. Fluorescence
is expected to increase during hypoxia and low pH due to the hemerythrin like structure of the
protein Rv2633c and its apparent regulation by PhoPR and WhiB3.
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The transcription factors PhoPR and WhiB3 have been proven to be crucial to Mtb
survival in macrophages (17). Therefore, it is important to determine if the gene of interest is
regulated by either of these factors since that would imply the gene may have a key role in
helping the bacteria live under stress. The relationship of Rv2633c to the transcription factor
PhoPR can be seen by the way Rv2633c fluorescent levels are significantly lower in PhoPR
mutants. This leads us to conclude that Rv2633c is regulated by this transcription factor. This is
significant because PhoPR plays a role in TB pathogenesis. Similar experiments will be carried
out using a WhiB3 mutant in the lab, to confirm regulation of Rv2633c by this transcription
factor.
Due to the similar expression profiles of Rv2632c and Rv2633c in the macrophage
infection microarray (Figure 3), it is important to determine whether the two genes are located
on the same operon. Genes located on the same operon often have similar roles. If this were
the case for these genes the function of Rv2632c should be taken into consideration as well. RTPCR suggests that Rv2632c and Rv2633c are not located on the same operon since the
intergenic region between the two genes could not be amplified. If the two genes are on
separate operons, then this region between genes would be on separate mRNA transcripts.
Therefore, when the primers bind to the sequence, they are not on complimentary strands and
cannot amplify the fragment. Since microarray data implied otherwise, qRT-PCR was conducted
to get a more specific, quantitative measure of this relationship. qRT-PCR suggests that Rv2632c
and Rv2633c are both abundant in the cell based on similar relative abundance to the gene sigA
which is known to be highly expressed in Mtb. High expression of Rv2633c is consistent with the
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vibrant magenta color of the reporter in Mtb. These two genes also appear to be similar in
expression levels, which would be consistent with an operon. qRT-PCR will also be performed
with RNA from ∆PhoPR and ∆WhiB3 strains. With this RNA, it will be possible to see how the
abundance of these genes are affected by mutation in the transcription factors. It is predicted
that their relative abundance will drop significantly in the transcription factor mutant if the
gene is regulated by it. RNA from Mtb during a macrophage infection will also be used for qRTPCR to determine if the abundance of Rv2633c increases during cell stress.
The qRT-PCR data, the heat map, and the two genes being adjacent suggest they may
reside on the same operon. However, the RT-PCR data does not agree with this so further
investigation must be conducted to conclude the operon organization of Rv2632c and Rv2633c.
Based on the results of qRT-PCR performed with RNA from ∆PhoPR and ∆WhiB3 strains and
RNA from Mtb macrophage infection, it will be possible to see if the levels of Rv2632c and
Rv2633c are coordinately regulated. Confirming operon organization may also include
attempting to find a promoter region for Rv2632c or using primer extension to locate the 5’ end
of the mRNA transcript.
Similarly, the knock out strain will be used with reverse genetics. Once this construct in
transformed into the cell, Rv2633c will not be present any more. By exposing the bacteria to
the same environmental stresses described above, we will identify conditions under which
Rv2633c is required for the survival and growth of mycobacteria. Based on its sequence
homology to hemerythrins and Dps, both proteins involved in stress survival, we hypothesize
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that the knock-out mutant will exhibits reduced tolerance for stresses such as hypoxia, acid pH,
and starvation.
Mtb has many mechanisms still uncharacterized to maintain long term infection.
Rv2633c may be one of these mechanisms, using a hemerythrin-like domain to sense hypoxia
and oxidative stress coupled to a Dps domain to protect the cell’s DNA during these conditions.
By defining novel Mtb virulence mechanisms like Rv2633c, it will be possible to develop new
drugs that will target TB in a way to improve the quality of life for any people, and save millions
of lives every year.
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APPENDIX: PRIMER CATALOG
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Primer Name
2633pro_mCh_F

Sequence (5’-3’)

Function

TAGAGGATCGTCGGC

Forward primer amplifying the Rv2633c promoter

ACC/CGGGTGGGCAG

region ~1,000 bp upstream of the gene.

GAGCT
2633pro_mCh_R

TCGCCCTTGCTGACCA

Reverse primer amplifying the Rv2633c promoter

T/TTCGTTGCTCTATTC

region ~1,000 bp upstream of the gene.

CGTATTCG
2633c/32cRT_F

GACGTAGAGGAACGC Forward primer for amplifying the intergenic region
GACAT

2633c/32cRT_R

2633c_Dn_F

between Rv2632c and Rv2633c

CAAACCAACACCCACC Reverse primer for amplifying the intergenic region
ATCT

between Rv2632c and Rv2633c

CGGTTGTCAGTGCTA

Forward primer for amplifying the region directly

GGC

downstream of Rv2633c for creating the knock out
strain

2633_Dn_R

CCTCGGTCAGCAGTT

Reverse primer for amplifying the region directly

GGC

downstream of Rv2633c for creating the knock out
strain

2633_Up_F

GACGTGGCGGGATGT

Forward primer for amplifying the region directly

TAATC

upstream of Rv2633c for creating the knock out
strain
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2633_Up_R

CGAATACGGAATAGA

Reverse primer for amplifying the region directly

GCAACGA

downstream of Rv2633c for creating the knock out
strain

pFCKO_dn_F

pFCKO_dn_R

pFCKO_Up_F

pFCKO_Up_R

M13F

GTGAGTCGTATTACA

Forward primer for opening the pFCKO vector

ATTCACTGG

downstream of the Hyg marker

CGCTAAATTCAATTCG

Reverse primer for opening the pFCKO vector

CCCTAT

downstream of the Hyg marker

GGGACTAGTCCTGCA

Forward primer for opening the pFCKO vector

GGTTTAAA

upstream of the Hyg marker

CCAAGCTCAGAATTA

Reverse primer for opening the pFCKO vector

ACCCTCACTAAA

upstream of the Hyg marker

CAGGAAACAGCTATG

Forward primer used for screening the knockout for

ACCATGA

the

upstream

fragment,

hyg

marker,

and

downstream fragment
M13R

CGTCGTTTTACA

Reverse primer used for screening the knockout for
the

upstream

fragment,

hyg

marker,

and

downstream fragment
pVVmCh_FC_Rpr GGTGCCGACGATCCT

Reverse primer for amplifying during Round the

o

CTA

Horn PCR

SigA_F

CGACGCTGAACCAGA

Forward primer used as a control for qRT-PCR
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CCT
SigA_R

TTCGAGGTCTTCGTG

Reverse primer used as a control for qRT-PCR

GTCTT
Rv2632c_F

Rv2632c_R

Rv2633_F

Rv2633_R

ATTGATGTGCTGATTG Forward primer for amplifying inside the Rv2633c
AGGTTG

gene during qRT-PCR

ATATCCGACGACGTC

Reverse primer for amplifying inside the Rv2633c

AAAGC

gene during qRT-PCR

ATGCCTACGACGTATT Forward primer for amplifying inside the Rv2632c
AAAGCG

gene during qRT-PCR

GAACACGTTCCACTCT

Reverse primer for amplifying inside the Rv2632c

TCTTCA

gene during qRT-PCR
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